Barclays Cuts Crocs (NASDAQ:CROX) Price Target to $125.00

Crocs (NASDAQ:CROX) had its price target decreased by Barclays from $164.00 to $125.00 in a research note released on Tuesday, Benzinga reports. Barclays currently has an overweight rating on the textile maker’s stock.

A number of other brokerages have also commented on CROX. Williams Trading upgraded Crocs from a “hold” rating to a “buy” rating and boosted their price target for the company from $135.00 to $163.00 in a report on Thursday, August 22nd. Guggenheim initiated coverage on Crocs in a research note on Wednesday, October 9th. They issued a “buy” rating and a $182.00 target price on the stock. KeyCorp raised their price target on shares of Crocs from $149.00 to $155.00 and gave the stock an “overweight” rating in a research note on Thursday, September 26th. UBS Group cut their price objective on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 16th. Finally, Raymond James downgraded shares of Crocs from a “strong-buy” rating to an “outperform” rating and set a $164.00 target price for the company. in a research report on Friday, August 2nd. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $154.00.

Crocs Price Performance

Shares of CROX opened at $107.82 on Tuesday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.95 and a current ratio of 1.50. The firm has a market capitalization of $6.40 billion, a PE ratio of 8.11, a P/E/G ratio of 1.35 and a beta of 1.99. The stock has a 50 day simple moving average of $137.05 and a 200 day simple moving average of $138.45. Crocs has a 52-week low of $74.00 and a 52-week high of $165.32.

Crocs (NASDAQ:CROX) last issued its quarterly earnings data on Tuesday, October 29th. The textile maker reported $3.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.47. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Crocs had a net margin of 20.02% and a return on equity of 53.20%. The firm’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.25 earnings per share. Sell-side analysts predict that Crocs will post 12.88 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director John B. Replogle bought 2,240 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were bought at an average price of $112.60 per share, for a total transaction of $252,224.00. Following the transaction, the director now directly owns 9,304 shares of the company’s stock, valued at approximately $1,047,630.40. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total value of $1,402,433.72. Following the completion of the sale, the director now directly owns 81,254 shares of the company’s stock, valued at $10,756,404.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director John B. Replogle bought 2,240 shares of the stock in a transaction on Wednesday, October 30th. The stock was purchased at an average price of $112.60 per share, for a total transaction of $252,224.00. Following the completion of the purchase, the director now owns 9,304 shares of the company’s stock, valued at approximately $1,047,630.40. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 2.72% of the company’s stock.

Institutional Investors Weigh In On Crocs

Several large investors have recently added to or reduced their stakes in CROX. Davis Investment Partners LLC boosted its holdings in shares of Crocs by 0.8% in the third quarter. Davis Investment Partners LLC now owns 9,673 shares of the textile maker’s stock worth $1,362,000 after acquiring an additional 77 shares during the period. Nisa Investment Advisors LLC boosted its stake in Crocs by 8.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock worth $152,000 after purchasing an additional 85 shares during the period. Central Pacific Bank Trust Division grew its holdings in Crocs by 8.0% during the 3rd quarter. Central Pacific Bank Trust Division now owns 1,350 shares of the textile maker’s stock valued at $195,000 after buying an additional 100 shares in the last quarter. 180 Wealth Advisors LLC increased its position in shares of Crocs by 1.6% during the second quarter. 180 Wealth Advisors LLC now owns 7,248 shares of the textile maker’s stock valued at $1,036,000 after buying an additional 111 shares during the period. Finally, Clear Harbor Asset Management LLC lifted its holdings in shares of Crocs by 4.0% in the third quarter. Clear Harbor Asset Management LLC now owns 3,014 shares of the textile maker’s stock worth $436,000 after buying an additional 115 shares in the last quarter. Hedge funds and other institutional investors own 93.44% of the company’s stock.

Crocs Company Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.